Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics ...

In the 10-K report, Amneal Pharmaceuticals disclosed its summarized consolidated cash flows for the years ended December 31, ...

Industry leaders warn that potential US tariffs on Indian pharmaceutical exports could increase drug costs for American ...

“There's always going to be somebody who is going to be trying to bring falsified medicines into the marketplace, that's just the way of the world unfortunately” The Falsified Medicines ...

ANI Pharmaceuticals beat Q4 estimates with strong sales growth and raised its 2025 revenue and EPS outlook, driven by ...

Generated record quarterly net revenues of $190.6 million, representing year-over-year growth of 44.8%Total Rare Disease quarterly net revenue of ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of ...

Reports Q4 revenue $190.6M vs. $131.65M last year. Nikhil Lalwani, President and CEO of ANI stated, “We’re thrilled to report another year of ...